Poster Session III Saturday, May 30; 16:00-18:00 Imaging: Radiometals 126 Stability comparison study using gel electrophoresis and radio-HPLC Heesu Ahn (National University School of Medicine, Korea) 127 Synthesis and in ovo evaluation of the neuropeptide cathelicidin 89Zr-CATH2 Gert Luurtsema (University of Groningen, Netherlands) 128 Synthesis of 99mTc(CO)3 labeled 2-(4-chloro)phenyl-imidazo[1,2-a]pyridine analog (99mTc-CB256) as a new TSPO-selective SPECT radiotracer Ji Young Choi (Seoul National University Bundang Hospital, Korea) 129 Evaluation of 99mTc-labelled FR-targeting Imaging Probe with Novel Linkage to Improve the Tumor Uptake Xianzhong Zhang (Xiamen University, China) 130 Preparation and evaluation of 64Cu-labeled streptavidin/biotin-based RGD dimer for dual PET/optical imaging of αvβ3 receptor expression Hyunjung Kim (Samsung Medical Center, Korea) 131 68 132 203 133 Copolymer-Based Functional SPECT/MR Imaging Agent for Asialoglycoprotein Receptor Targeting Manli Song (Xiamen University, China) 134 Synthesis and biological evaluation of new bone-seeking [Re/99mTc(CO)3(κ3-L)] complexes with [NSN] and [NSO] bifunctional chelators George Makris (Aristotle University Of Thessaloniki, Greece) 135 Characterization and Development of Two Phage Display Selected Anti-ErbB3 Peptides Susan L. Deutscher (Harry S. Truman Veterans Memorial Hospital, United States) 136 99m 137 Target-Specific Radiolabeled Gold Nanoconjugates Raghuraman Kannan (University of Missouri, United States) 138 Synthesis, Characterization and Imaging of a 99mTc(I)-Tetrazine Tridentate Ligand Complex for Bioorthogonal Chemistry Zainab Ahmad (McMaster University, Canada) 139 Synthesis, In Vitro Evaluation, and In Vivo PET/CT of 64Cu-labeled CD11b-targeting Probe Haixun Guo (University of Louisville, United States) 140 Synthesis and In Vitro Bacteria Binding of 68Ga-labeled Yersiniabactin Haixun Guo (University of Louisville, United States) 141 A Novel SPECT Metalloprobe 67Galmydar for Myocardial Perfusion Imaging Scott E. Harpstrite (Washington University School of Medicine, United States) 142 Development of ring substituted pyridine based chelates for fac-[MI(CO)3]+ (M=Re, 99mTc) based radiopharmaceuticals Thomas R. Hayes (Washington State University, United States) 143 Clickable bifunctional cross-bridged phosphonate-based chelator through alkyne and aldehyde modifications Carolyn J. Anderson (University of Pittsburgh, United States) Ga-labeled peptides for targeting phosphatidylserine (PS) in apoptosis Amanda Perreault (University of Alberta, Canada) Pb-labeled radiotracer targeting metastatic melanoma. Izabela Tworowsk (1RadioMedix Inc., United States) Tc(I) probes. Samantha R. Slikboer (McMaster University, Canada) 144 Enhancing [64Cu]-NODAGA-Exendin-4 Uptake into GLP-1 Receptor Expressing Cells Using an Agoallosteric Modulating Quinoxaline Derivative: A Step Towards Improved β-Cell imaging. Gregory D. Bowden (Eberhard Karls Universität Tübingen,Germany) 145 Isothiocyanate-functionalized bifunctional chelates for 99mTc and Re complexes for uPAR targeting in prostate cancer Paul D. Benny (Washington State University, United States) 146 Clickable cross-bridged chelator to prepare dimeric peptide for targeted PET imaging Marie-Caline Abadjian (San Diego State University, United States) 100 Synthesis of [123I]Iodoaniracetam, a SPECT agent for Brain Imaging David W. Blevins (University of Tennessee, United States) 088 Influence of chelators on targeting properties of 111In and 68Ga labeled GRPR antagonist Irina Velikyan (Uppsala University, Sweden) PET: F-18 235 Identification and in vivo evaluation of [18F]MNI-617 as a radioligand for PDE4 imaging in non human primate Caroline Papin (Molecular NeuroImaging, United States) 236 In vitro evaluation of new tau PET tracer candidates using [ 18F]T808 and [18F]T808 AD brain slice autoradiography binding inhibition studies Guy Bormans (KU Leuven, Belgium) 237 Optimisation of the synthesis and purification of 18F-4-fluorobenzaldehyde on a FASTlab cassette for labelling of macromolecules Julian Grigg (GE Healthcare, United Kingdom) 239 Using Biotransformations for Radioligand Discovery and Validation – Preparative Liver Microsome Incubations Shed Further Light on the Impact of Radiometabolites on In Vivo Imaging Magnus Schou (AstraZeneca, Sweden) 240 Synthesis and Biological Evaluation of 18F-labeled FMTPD as a Focal Adhesion Kinase-Targeted Tumor Imaging Agent Yu Fang (Beijing Normal University, China) 241 First radiosynthesis of 18F-labeled anle138b a potential tracer for imaging of neurodegenerative diseases associated with protein deposition in brain Bernd Neumaier (University Clinic Cologne, Germany) 242 Construction of 18F-labeled molecules via metal-free cross-coupling reactions of radiofluorinated tosylhydrazones Bernd Neumaier (University Clinic Cologne, Germany) 243 Radiosynthesis and preclinical evaluation of new Al18F-labelled Urea-based PSMA inhibitors for PET imaging of prostate cancer Frederik W. Cleeren (University of Leuven, Belgium) 245 Synthesis and pharmacological evaluation of hydrophilic [F-18]-labeled GBR12935 derivatives as novel PET imaging agents for dopamine transporter Ling-Wei Hsin (National Taiwan University, Taiwan) 246 Synthesis of deuterium-substituted [18F]fluoromethyl-PBR28 and its initial PET evaluation compared with [18F]fluoromethyl-PBR28 in a rat model of neuroinflammation Byung Chul Lee (Seoul National University Bundang Hospital, Korea) 248 Synthesis, characterization, and in vivo evaluation of 18F-labeled 2-phenyl-imidazo[1,2-a]pyridine analog (18FCB251) as a new TSPO PET radiotracer Byung Chul Lee (Seoul National University Bundang Hospital, Korea) 247 A simplified production method of 18F-FMISO using a cation exchange resin for the deprotection reaction. Yuji Kuge (Hokkaido University, Japan) 249 Development of 18F-labeled PET Probes for C-MET Imaging Zhen Cheng (Stanford University, United States) 250 Evaluation of Trehalose Derivatives as Radiotracers Specific for Tuberculosis in Animal Models of Disease Gwendolyn A. Marriner (National Institutes of Health, United States) 251 Synthesis and First ex-vivo Results of [19F]-Fluoroethyl-resorufin for Imaging of Cerebral Amyloid Angiopathy in APP23 Mice Andreas Maurer (Eberhard Karls University Tübingen, Germany) 252 The Automated Production of 18F-Labeled PET Molecular Imaging Probes using a Microfluidic Chip-based Synthesizer Mingwei Wang (Fudan University Shanghai Cancer Center, China) 253 Clinical grade [18F]FTC-146: Radiosynthesis of sigma-1 receptor ligand for human PET studies Bin Shen (Stanford University, United States) 254 Microfluidic optimization and production of [18F]FP-TZTP Giancarlo Pascali (ANSTO, Australia) 255 Synthesis of [18F]Tetrafluoroborate via Radiofluorination of BF 3 Huailei Jiang (Mayo Clinic, United States) 256 Synthesis of radiobrominated amino acid derivatives via silicon-bromine exchange reaction Shigeki Watanabe (Japan Atomic Energy Agency, Japan) 257 A F-18 Labeled Enantiomeric PET Radiotracer for σ1 Receptors Xuyi Yue (Washington University in St. Louis, United States) 258 Development of 18F-Labeled Peptides for Imaging EGFL7 in Prostate Cancer Leonard Luyt (University of Western Ontario, Canada) 259 Novel Microscale Automated System for F-18 Radiopharmaceutical Synthesis Joe O. Armstrong (University of Washington, United States) 260 Synthesis of 18F-TH302 for PET hypoxic tumor imaging Dhanabalan Murali (University of Wisconsin, United States) 261 Synthesis and biological evaluation of [18F]DOPP for FAAH imaging Yu-Shin Ding (NYUMC, United States) 262 Improved Syntheses of Reference Standard and Precursors for Tau Imaging Agent, [18F]AV-1451 Carey L. Horchler (Avid Radiopharmaceuticals, United States) 263 Intricacies of 18F-labelling of exendin-4 via click chemistry Cheng-Bin Yim (University of Turku and Åbo Akademi University, Finland) 264 Facile 18F radiosynthesis of olaparib derivatives as potential poly[ADP-ribose] polymerase 1 (PARP-1) imaging agents Dong Zhou (Washington University in Saint Louis, United States) 265 A Perfluoroaryl-Cysteine SNAr Chemistry Approach towards F-18 labeling of Bioactive Peptides Jitendra K. Mishra (St. Jude Children's Research Hospital, United States) 266 Rapid, microfluidic radiosynthesis of a [18F]F-Py-GnRH peptide Robin C. Cumming (University of California Davis, United States) 267 Synthesis and biological evaluation of a novel α,α-diakyl amino acid PET tracer for brain tumor and prostate cancer imaging. Ahlem Bouhlel (Washington University in St Louis, United States) 268 Radiolabelling of a α-synuclein PET radioligand candidate using a copper-mediated nucleophilic fluorination reaction Christophe Plisson (Imanova, United Kingdom) 269 Modelling Reactions for F-18 Labeling of Chitosan Nanoparticles Ana Lima Oubina (University of Debrecen, Hungary) 270 A 18F Labeling Strategy for Near Infrared Fluorophores. Multi-Modal Probes for Reactive Oxygen Species Salma Al-karmi (McMaster University, Canada) 271 Production of [F-18]THK-5117 using Siemens Explora chemistry module Tobey J. Betthauser (University of Wisconsin - Madison, United States) 272 PET imaging and ex vivo brain autoradiography in a mouse model of Alzheimers disease using the TSPO tracers [18F]DPA-714 and [18F]F-DPA Merja Haaparanta-Solin (University of Turku, Finland) 213 Automated synthesis of a 18F-labeled lysine-urea-glutamate for PSMA imaging Frank Wuest (University of Alberta, Canada) 410 Radiosynthesis and In Vitro Evaluation of [18F] FP-PEAQX as a Potential PET Radioligand for Imaging the GluN2A Subunit of the NMDA Receptor Simon Ametamey (ETH Switzerland) 411 Preliminary Evaluation of Dual 18F- and 125I-Labeled Benzyloxybenzenes for Comparative Imaging ofβAmyloid Plaques H. Jia (Beijing Normal University, China) PET: C-11 and Other 321 Cellular uptakes of novel gold nanoparticle conjugates via radioactivity analysis and photoacoustic imaging Xia Shao (University of Michigan, United States) 327 Radiosynthesis of [11C]Allyl Amides by Amidation of a [11C]Carboxylate Intermediateintermediate Xia Shao (University of Michigan, United States) 322 Radiosynthesis of the auxin class plant growth hormone 4-chloro-3-indolyl[1-11C]acetic acid Paul Ellison (University of Wisconsin, United States) 323 11 324 Radiosynthesis and Selective Purification of [11C]Palmitic Acid (PA) using a Single Disposable Cartridge James M. Kelly (Weill Cornell Medical College, United States) 325 Synthesis of Radiolabeled Glycogen Synthase Kinase 3β Inhibitors for CNS imaging Peter J. Scott (University of Michigan, United States) 326 Evaluation of Bioorthogonal Reactive Pairs for Cathepsin B Imaging Patricia Edem (McMaster University, Canada) 328 Rapid Synthesis of [11C]Urea derivatives by [11C]CO2 Incorporation: Application to novel mGluR1 brain imaging probes. Abdul Karim Haji Dheere (King's College London, United Kingdom) 329 Synthesis of C-11 and F-18 labeled NOP 46 - A potential marker for chronic pain Shunichi Oya (Columbia University, United States) 330 Radiosynthesis and evaluation of the 5-HT2A inverse agonist: [11C]pimavanserin Matthias Herth (University of Copenhagen, Denmark) 331 Synthesis of Dipeptide [11C]Phe-Phe-NH2, a High Affinity Ligand for the Substance P 1-7 Specific Binding Site Aleksandra Pekošak (VU Medical Center, Netherlands) C ammonium thiocyanate: a novel 11C synthon for PET radiolabelling Tom Haywood (Imperial College London, United Kingdom) 332 Radiolabelling and initial in vivo evaluation of 11C N-methyl Linsitinib (OSI 906) targeting IGF-1 and insulin receptors Dirk A. Bender (Aarhus University Hospital, Denmark) 333 Development of efficient construction of [11C]carbamate moiety using [11C]COCl2 Masayuki Fujinaga (National Institute of Radiological Sciences, Japan) 334 Selective O-[11C]methylation of 1-(3-hydroxyphenyl)piperazine Szabolcs Lehel (Copenhagen University Hospital, Denmark) 335 Synthesis and preclinical evaluation of [11C]/[3H]Alisertib, an aurora kinase A (AURKA) inhibitor Joost Verbeek (VU University medical center, Netherlands) 336 The introduction of an useful organic strong base, 1,8-bis(tetramethylguanidino)naphthalene for [11C]methylation: a preparation of [11C]raclopride Sang-Yoon Lee (Gachon University, Korea) 337 A Simple Method for Evaluation of [11C]PBR28 Partitioning Within Blood Mark A. Green (Indiana University, United States) 338 GMP compliant synthesis of [11C]phenytoin by rhodium mediated [11C]carbon monoxide carbonylation performed in disposable glass vials Jonas Eriksson (Uppsala University Hospital, Sweden) 339 Synthesis of N-succinimidyl-3-fluoro-4-[124I]-iodobenzoate (S-FIB), a novel protein iodination analogue Christina L. Brown (3DImaging, LLC., United States) Radiopharmacy 369 High output [18F]FDOPA production on AllInOne (Trasis) at commercial scale. Muhammad Otabashi (Trasis SA, Belgium) 370 Azeotropic drying free FDG synthesis and its application to a microfluidic platform Simon K. Lindner (University of Munich LMU, Germany) 371 4S-(3-[18F]Fluoropropyl)-L-glutamic acid (FSPG): Biodistribution and tumor uptake in SLC7A11-KO mice Matthias Friebe (Piramal Imaging, Germany) 374 Comparative biodistribution of 99mTc-duramycin: influence of species, purification and kit composition Luca Palmieri (University Hospital Antwerp, Belgium) 375 Reproducibility of O-(2-[18F]fluoroethyl)-L-tyrosine kinetics in brain tumors and influence of dexamethasone therapy: A PET study in rat gliomas Johannes Ermert (Forschungszentrum Jülich, Germany) 376 Radiochemical stability of 68Ga- and 177Lu-labeled high-affinity DOTATATE (DOTA-3-iodo-Tyr3-octreotate) Dirk Mueller (University Hospital Halle(Saale), Germany) 377 Synthesis and evaluation of 99mTc labeled metronidazole analogs HYNIC-ADIBO-MN via copper-free click chemistry for tumor hypoxia imaging Liqin Liu (University of Science and Technology Beijing, China) 378 [99mTc]ZOL - First in vivo imaging in dogs Daniela Haeusler (Medical University of Vienna, Austria) 379 Synthesis and evaluation of two novel Tc-99m-labeled lactam bridge-cyclized melanocortin peptides for melanoma SPECT imaging Thomas P. Quinn (University of Missouri, United States) 380 Reactivity and structure relations in Mn(I), Re(I) and Tc(I)-tricarbonyl complexes – impact on drug design. Hendrik G. Visser (University of the Free State, South Africa) 381 In vivo imaging and characterization of [ 18F]DPA-714, a potential new TSPO ligand, in mouse brain and peripheral tissues using small-animal PET Mariarosaria Panico (CNR, Italy) 382 Metabolism study of radiolabeled hydrazinocurcumin derivative Sarah Shin (Samsung Medical Center, Korea) 363 A 99mTc-labeled antibody for the dog EGF-receptor - a preclinical evaluation Christina Rami-Mark (Medical University of Vienna, Austria) Targetry, Production and Separations 383 Chemical Conversion of 11CO2 to 11CO via Silacarboxylic Acids: Applications in Palladium-Mediated Carbonylations Patrik Nordeman (Uppsala University, Sweden) 385 Improved Production of Zr-89 from Cyclotron using a Second-Generation Solution Target Mukesh K. Pandey (Mayo Clinic, United States) 386 82 387 Improved elution procedure of 3’-Deoxy-3’-[18F]fluorothymidine [18F]FLT for safer human injectable radiotracer Mohammed H. Al Qahtani (King Faisal Specialist Hospital and Research Center Riyadh, Saudi Arabia) 388 A study on remote production of 43Sc from natCaO target via the natCa(α,x)-reaction Kotaro Nagatsu (National Institute of Radiological Sciences, Japan) 389 A feasibility study on 68Ge production from elemental natGa by in-situ extraction process Kotaro Nagatsu (National Institute of Radiological Sciences, Japan) 390 Application of Compton-suppressed Gamma-Ray Spectroscopy for Improved Quality Control for production of 82Sr. Suzanne V. Smith (Brookhaven National Lab, United States) Alternative Methods for the Production of Mo-99: non-Fission Based Solid-State, Mo-100 (g,n) Mo-99, and sub-Critical Solution-State, U-235 (n,f) Mo-99 David A. Rotsch (Argonne National Laboratory, United States) 391 Sr/82Rb production with an SR resin®: characterization and quantification by mass spectrometry of radiation-induced degradation of various 18-crown-6 crow-ethers Sandrine C. Huclier-Markai (SUBATECH/ARRONAX, France) Therapy 401 Promising anti-Gram-negative antimicrobial peptides (AMPs): Radiolabeling and biodistribution profiles Unai Cossío (CIC biomaGUNE , Spain) 402 Production and In Vivo Evaluation of Radioactive MGF-198AuNPs for Prostate Cancer Treatment Amal Y. Al-Yasiri (University of Missouri, United States) 403 Radiosynthesis and Quality Control of Nanosized Resveratrol-Au-198 T M. Sakr (Egyptian Atomic Energy Authority, Egypt) 404 Synthesis of radiolabelled boron-rich functionalized NPs as boron carriers for boron neutron capture therapy Kiran B. Gona (CICbiomaGUNE, Spain) 405 Strategies to Probe the Chemistry of Actinium Justin J. Wilson (Los Alamos National Laboratory, United States) 406 Hypoxia imaging biomarker, Tc-99m-HL91, in injectable in situ forming thermosensitive implant at a murine tumor mode Bi-Fang Lee (National Cheng Kung University Hospital, Taiwan) 407 cGMP Kit Production of CycloSam® (Sm-153-DOTMP), A New Therapeutic Bone Agent R K. Frank (IsoTherapeutics Group LLC, United States) 408 Treatment with Samarium-153-DOTMP in Dogs with Naturally Occurring Osteosarcoma for Therapeutic Benefit and as a Translational Model Kimberly A. Selting (University of Missouri, United States)
© Copyright 2024